Ilkka Oyj
5.3.2026 18:00:00 CET | Globenewswire | Press release
Ilkka Oyj: Acquisition of own shares on 5 March 2026
Ilkka Oyj: Acquisition of own shares on 5 March 2026
Ilkka Oyj Stock Exchange Release 5 March 2026, at 07:00 p.m. EET
Ilkka Oyj: Acquisition of own shares on 5 March 2026
| Date | 5 March 2026 | |
| Exchange transaction | Buy | |
| Share trading code | ILKKA2 | |
| Amount, shares | 2,888 | |
| Average price/share (EUR) | 4.2693 | |
| Total cost (EUR) | 12,329.74 |
After the acquisitions Ilkka Oyj holds a total of 108,231 treasury shares (ILKKA2).
On behalf of Ilkka Oyj
Danske Bank A/S, Finland Branch
Antti Väliaho Jonathan Nyberg
For more information, please contact:
Olli Pirhonen, CEO, Ilkka Oyj
olli.pirhonen@ilkka.com
DISTRIBUTION
Nasdaq Helsinki
Main media
www.ilkka.com
Ilkka Oyj in brief
Ilkka is a marketing and technology company that offers professional, data and technology services in digital marketing and communications. The core of Ilkka's business is formed by the software company Liana, a pioneer in marketing and communication technology, and its Swedish subsidiary Ungapped; the leading expert in data-driven sales and marketing, Profinder; Finland's leading WordPress digital agency Evermade; Finland's leading social media marketing expert agency MySome; and the strategic B2B marketing partner Myynninmaailma. Our success relies heavily on knowing the entire purchase path and utilizing modern technology, data, and AI. Our international focus is particularly on Sweden and the emerging markets in the Middle East. The group's services are provided by approximately 330 marketing, technology, and data experts.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
CoinShares International Limited5.3.2026 21:20:55 CET | Press release
CoinShares CEO to Participate in Canaccord Genuity Virtual Digital Assets Symposium
Wood Mackenzie5.3.2026 21:11:29 CET | Press release
How the Middle East conflict is reshaping gas and LNG markets
Zealand Pharma5.3.2026 19:45:00 CET | Press release
Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity
F. Hoffmann-La Roche Ltd5.3.2026 19:45:00 CET | Press release
Roche announces positive Phase II results for petrelintide, an amylin analog developed for people living with overweight and obesity
Esaote5.3.2026 19:30:25 CET | Press release
Esaote launches the new MyLabTM E85 GTS ultrasound system in Vienna
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom